A Randomized, Comparative Open Label Study of Imipenem Versus Cefepime in Spontaneous Bacterial Peritonitis and to Evaluate the Risk Factors for Treatment Failure
Phase of Trial: Phase III
Latest Information Update: 24 Nov 2016
Price : $35 *
At a glance
- Drugs Cefepime (Primary) ; Imipenem (Primary) ; Albumins
- Indications Bacterial peritonitis
- Focus Therapeutic Use
- 21 Jul 2016 Status changed from recruiting to completed.
- 02 Apr 2015 Planned End Date changed from 1 Dec 2014 to 1 Dec 2015 as reported by ClinicalTrials.gov record.
- 02 Apr 2015 Planned primary completion date changed from 1 Dec 2014 to 1 Dec 2015 as reported by ClinicalTrials.gov record.